Hypro Heart Check – Advance

Cardiovascular diseases pose a significant global health threat, resulting in 17.9 million deaths annually, as reported by the World Health Organization (WHO). These conditions, affecting individuals of all age groups, emphasize the importance of early detection through thorough heart function assessments. Among the array of cardiovascular issues, coronary artery disease emerges as the most prevalent, causing plaque buildup in arteries and disrupting blood flow to the heart, leading to heart attacks, angina, and heart failure. Recognizing the gravity of such diseases, Hypro Diagnostics offers cardiac checkup packages with 72 tests, aiming to comprehensively evaluate the patient’s cardiac system and identify potential ailments in their early stages. The diagnostic evaluations integrated into these cardiac function tests play a pivotal role in early detection and diagnosis. Tests like the Glucose Fasting Test assess blood pressure, a crucial indicator of artery damage that can impact heart blood flow. The High-sensitivity C-reactive Protein (HSCRP) Test gauges inflammation risk by detecting C-reactive protein levels. The Lipoprotein A (LP-A) Test assesses cholesterol-carrying lipoproteins, providing insights into cardiovascular disease risk. The Complete Blood Count (CBC) measures components like hemoglobin and platelets, aiding in the detection of conditions such as anemia and assessing cardiac health risks. Furthermore, the Lipid Profile Test scrutinizes levels of triglycerides, HDL, LDL, VLDL cholesterol, and total cholesterol—essential indicators for potential heart problems. Renal Function and Liver Function Tests assess kidney and liver health, respectively, as complications in these organs can elevate the risk of heart disease. By analyzing the results of these tests, Hypro Diagnostics aims to empower healthcare professionals to formulate early treatment plans, enabling effective management and combat of cardiac issues and ultimately contributing to improved patient outcomes.